2-bromopalmitate has been researched along with Diabetes Mellitus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ailhaud, G; Amri, EZ; Cawthorne, MA; Gaillard, D; Grimaldi, PA; Ibrahimi, A; Teboul, L; Young, P | 1 |
Chauvet, MC; Henly, DC; Phillips, JW | 1 |
2 other study(ies) available for 2-bromopalmitate and Diabetes Mellitus
Article | Year |
---|---|
Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
Topics: 3T3 Cells; Adipose Tissue; Animals; Carrier Proteins; Cells, Cultured; Diabetes Mellitus; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression Regulation; Hypoglycemic Agents; Kinetics; Mice; Neoplasm Proteins; Nerve Tissue Proteins; Palmitates; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones | 1994 |
Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats.
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids; Glucose; Hyperglycemia; Liver; Obesity; Oxidation-Reduction; Palmitates; Rats; Rats, Zucker; Reference Values | 1999 |